ProShares Ultra Nasdaq Biotechnology (BIB) News Today $48.34 +0.43 (+0.90%) Closing price 07/3/2025 01:04 PM EasternExtended Trading$46.86 -1.49 (-3.07%) As of 07/3/2025 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock BIB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Pass Above 50 Day Moving Average - Should You Sell?July 5 at 4:47 AM | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) to Issue Dividend Increase - $0.17 Per ShareJune 25, 2025 | marketbeat.com22,406 Shares in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Acquired by IMC Chicago LLCJune 13, 2025 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above Fifty Day Moving Average - Should You Sell?May 5, 2025 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Pass Below Fifty Day Moving Average - Should You Sell?April 27, 2025 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Large Drop in Short InterestMarch 27, 2025 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) to Issue $0.13 Quarterly DividendMarch 27, 2025 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Below 50-Day Moving Average - What's Next?March 18, 2025 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above 50-Day Moving Average - Should You Sell?March 8, 2025 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest UpdateMarch 1, 2025 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Pass Above 50-Day Moving Average - Time to Sell?February 25, 2025 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Down 15.4% in JanuaryFebruary 16, 2025 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Pass Below 200-Day Moving Average - What's Next?February 15, 2025 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Pass Above 50 Day Moving Average - Here's What HappenedFebruary 15, 2025 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Pass Above 50-Day Moving Average - What's Next?February 7, 2025 | marketbeat.comShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Rises By 136.4%January 30, 2025 | marketbeat.comShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Declines By 43.6%January 29, 2025 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Below 50-Day Moving Average - Here's What HappenedJanuary 9, 2025 | marketbeat.comProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.3964December 24, 2024 | msn.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Large Decrease in Short InterestNovember 13, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Pass Below 50-Day Moving Average - Here's WhyNovember 6, 2024 | marketbeat.comShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Declines By 5.4%September 18, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechn (^BIB-IV)September 16, 2024 | ca.finance.yahoo.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Pass Above 50-Day Moving Average of $64.82September 13, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Cross Below 50 Day Moving Average of $64.12September 5, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Pass Above 50-Day Moving Average of $62.42August 22, 2024 | marketbeat.comProShares Ultra Nasdaq BiotechnologyAugust 20, 2024 | morningstar.comMShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Drops By 35.0%August 14, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above 50 Day Moving Average of $60.85August 2, 2024 | marketbeat.comBio-Techne backs Harvard spinout making 'ultra-sensitive' blood testing techJuly 30, 2024 | bizjournals.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Up 220.0% in JulyJuly 25, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Large Decline in Short InterestJuly 12, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Cross Above Fifty Day Moving Average of $57.71July 11, 2024 | marketbeat.comToth Financial Advisory Corp Grows Position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)June 30, 2024 | marketbeat.comShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Decreases By 26.8%June 29, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Increases Dividend to $0.26 Per ShareJune 26, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Significant Decline in Short InterestJune 13, 2024 | marketbeat.comCassaday & Co Wealth Management LLC Has $257,000 Holdings in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)June 9, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Cross Above 50 Day Moving Average of $54.20June 7, 2024 | marketbeat.comShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Drops By 25.3%May 30, 2024 | marketbeat.comCassaday & Co Wealth Management LLC Trims Stock Position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)May 22, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above 50-Day Moving Average of $54.17May 22, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Down 56.3% in AprilMay 11, 2024 | marketbeat.comProShares Ultra Bloomberg Natural Gas: Trading Short-Term Tailwinds (Rating Upgrade)April 29, 2024 | seekingalpha.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Significant Growth in Short InterestApril 25, 2024 | marketbeat.comShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Declines By 77.9%April 10, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Up 98.2% in MarchMarch 28, 2024 | marketbeat.comWall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy RichMarch 25, 2024 | investorplace.comProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.0403March 22, 2024 | msn.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Plans Dividend of $0.04March 20, 2024 | marketbeat.com Get ProShares Ultra Nasdaq Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for BIB and its competitors with MarketBeat's FREE daily newsletter. Email Address BIB Media Mentions By Week BIB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIB News Sentiment▼0.670.55▲Average News Sentiment BIB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIB Articles This Week▼10▲BIB Articles Average Week Get ProShares Ultra Nasdaq Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for BIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VanEck Pharmaceutical ETF News iShares Biotechnology ETF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIB) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
